Crystal structures of the 3C proteases from Coxsackievirus B3 and B4

被引:2
|
作者
Jiang, Haihai [1 ]
Lin, Cheng [2 ]
Chang, Jingyi [1 ]
Zou, Xiaofang [2 ]
Zhang, Jin [1 ]
Li, Jian [2 ]
机构
[1] Nanchang Univ, Sch Basic Med Sci, Jiangxi Med Coll, Nanchang 330031, Jiangxi, Peoples R China
[2] Gannan Med Univ, Coll Pharmaceut Sci, Ganzhou 341000, Peoples R China
基金
中国国家自然科学基金;
关键词
Coxsackievirus; CVB3; CVB4; 3C proteases; crystal structure; RNA-BINDING; 5-NONCODING REGION; MAIN PROTEASE; FOOT; HAND; RUPINTRIVIR; INHIBITION; PROTEINASE; DOMAINS;
D O I
10.1107/S2053230X24006915
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Enteroviruses cause a wide range of disorders with varying presentations and severities, and some enteroviruses have emerged as serious public health concerns. These include Coxsackievirus B3 (CVB3), an active causative agent of viral myocarditis, and Coxsackievirus B4 (CVB4), which may accelerate the progression of type 1 diabetes. The 3C proteases from CVB3 and CVB4 play important roles in the propagation of these viruses. In this study, the 3C proteases from CVB3 and CVB4 were expressed in Escherichia coli and purified by affinity chromatography and gel-filtration chromatography. The crystals of the CVB3 and CVB4 3C proteases diffracted to 2.10 and 2.01 angstrom resolution, respectively. The crystal structures were solved by the molecular-replacement method and contained a typical chymotrypsin-like fold and a conserved His40-Glu71-Cys147 catalytic triad. Comparison with the structures of 3C proteases from other enteroviruses revealed high similarity with minor differences, which will guide the design of 3C-targeting inhibitors with broad-spectrum properties.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 50 条
  • [21] Molecular epidemiology of Coxsackievirus B3
    Chu, Pei-Yu
    Ke, Guan-Ming
    Chen, Yao-Shen
    Lu, Po-Liang
    Chen, Hsiu-Lin
    Lee, Min-Sheng
    Chen, Bao-Chen
    Huang, Tsi-Shu
    Li, Yu-Chen
    Chou, Li-Chiu
    Wang, Sheng-Yu
    Lin, Kuei-Hsiang
    INFECTION GENETICS AND EVOLUTION, 2010, 10 (06) : 777 - 784
  • [23] MOPS and coxsackievirus B3 stability
    Carson, Steven D.
    Hafenstein, Susan
    Lee, Hyunwook
    VIROLOGY, 2017, 501 : 183 - 187
  • [24] The role of B lymphocytes in coxsackievirus B3 infection
    Mena, I
    Perry, CM
    Harkins, S
    Rodriguez, F
    Gebhard, J
    Whitton, JL
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04): : 1205 - 1215
  • [25] 2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors
    Kim, Bo-Kyoung
    Ko, Hyojin
    Jeon, Eun-Seok
    Ju, Eun-Seon
    Jeong, Lak Shin
    Kim, Yong-Chul
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 120 : 202 - 216
  • [26] On a class of unitary representations of the braid groups B3 and B4
    Albeverio, Sergio
    Rabanovich, Slavik
    BULLETIN DES SCIENCES MATHEMATIQUES, 2019, 153 : 35 - 56
  • [27] Soluble Coxsackievirus B3 3C Protease Inhibitor Prevents Cardiomyopathy in an Experimental Chronic Myocarditis Murine Model
    Lim, Byung-Kwan
    Yun, Soo-Hyeon
    Ju, Eun-Seon
    Kim, Bo-Kyoung
    Lee, You-Jung
    Yoo, Dong-Kyeom
    Kim, Young-Chul
    Jeon, Eun-Seok
    VIRUS RESEARCH, 2015, 199 : 1 - 8
  • [28] Cytotoxicity and Antiviral Activities of Haplophyllum tuberculatum Essential Oils, Pure Compounds, and Their Combinations against Coxsackievirus B3 and B4 #
    Hamdi, Assia
    Halouani, Aymen
    Aouf, Ines
    Viaene, Johan
    Marzouk, Belsem
    Kraiem, Jamil
    Jaidane, Hela
    Heyden, Yvan Vander
    PLANTA MEDICA, 2021, 87 (10/11) : 827 - 835
  • [29] Short syntheses of enantiopure calystegine B2, B3, and B4
    Skaanderup, PR
    Madsen, R
    CHEMICAL COMMUNICATIONS, 2001, (12) : 1106 - 1107
  • [30] PERINATAL TRANSMISSION OF COXSACKIEVIRUS B3 IN MICE
    MODLIN, JF
    BOWMAN, M
    JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01): : 21 - 25